semaglutide pill form side effects All you need to know about Wegovy weight loss tablet All you need to know

Telemedicine clinic Virta Health believes its members can achieve significant and sustained improvement in weight loss, even if a patient has stopped taking a GLP-1 drug, a newly released paper in | A new study in Diabetes Therapy from Virta Health says the company's carbohydrate restricted nutrition therapy allows patients who no longer want a GLP-1 prescription to still keep the weight off.

Retatrutide is an investigational triple-agonist peptide that simultaneously targets GLP1, GIP, and glucagon receptors to promote weight loss, improved insulin sensitivity, and enhanced metabolic regulation in research and clinical studies.

A new study uncovered an association between glucagon-like peptide-1 receptor agonist (GLP-1RAs) use and an increased risk of gastroparesis (GP) among patients with Type 2 diabetes.

Researchers know a lot about the link between soft drinks and being overweight, but less is known about how day-to-day consumption of soft drinks affects the body.

and increased insulin early AUC and C-peptide total and early AUCs

Although dedicated trials of GLP-1RAs in AITD are lacking, preliminary reports suggest potential impacton thyroid volume, thyroid function, and autoimmune activity